British 8.832893
ĠBi 8.824033
otech 0.7300566
ĠPl 6.8119364
c 0.011413156
, 2.1432464
Ġa 1.2898382
Ġrenowned 9.266943
Ġpharmaceutical 2.7978475
Ġcompany 0.69668686
, 0.9988673
Ġhas 1.0929333
Ġrecently 2.688026
Ġgenerated 8.464999
Ġconsiderable 4.7010946
Ġexcitement 2.8302193
Ġin 1.1034621
Ġthe 0.113888
Ġmedical 2.5560813
Ġfield 2.5767617
Ġwith 1.4008362
Ġits 1.2096065
Ġpromising 3.9774358
Ġcancer 2.8411276
Ġdrug 1.3639774
, 1.1519421
ĠMar 8.009033
im 2.2699156
ast 0.022818085
at 0.011427503
. 0.36832136
ĠThough 6.030632
Ġthe 1.2078611
Ġdrug 0.58782357
Ġdisplays 9.933469
Ġsignificant 3.2472794
Ġpotential 1.7026141
, 0.973228
Ġseveral 4.7499747
Ġconsiderable 9.083771
Ġhurdles 2.3662806
Ġremain 1.9648606
Ġon 3.775979
Ġthe 0.31656292
Ġpath 1.1305863
Ġto 0.30055624
Ġblockbuster 8.740814
Ġsuccess 1.7931639
. 0.17105916
Ċ 0.5612754
Mar 15.027419
im 0.0008726466
ast 0.011774775
at 0.0028675972
, 1.8992803
Ġan 2.4642987
Ġinnovative 4.0073867
Ġmatrix 7.361691
Ġmet 0.08392909
all 0.0031887644
op 0.008441896
rotein 0.07849315
ase 0.015580425
Ġinhibitor 0.84001154
, 0.3899796
Ġhas 1.4118147
Ġshown 1.8175523
Ġremarkable 3.2343946
Ġefficacy 2.326995
Ġin 0.34737757
Ġpre 3.4544365
clinical 0.6256799
Ġand 2.8270328
Ġearly 1.4449252
- 1.8713517
stage 0.37650824
Ġclinical 0.28589866
Ġtrials 0.46972227
, 2.3973153
Ġpotentially 5.575357
Ġrevolution 3.1680453
izing 0.09853118
Ġcancer 2.335441
Ġtreatment 0.48150447
. 0.42454383
ĠBy 4.512115
Ġinhib 0.96764827
iting 0.00013061494
Ġenzymes 4.204022
Ġcrucial 4.9719925
Ġfor 1.5772619
Ġtumor 1.1418078
Ġgrowth 1.1393484
Ġand 0.99449486
Ġprogression 2.8706276
, 0.04787341
ĠMar 0.59467554
im 0.00084264076
ast 0.0076018074
at 0.000353232
Ġhas 1.4519328
Ġdemonstrated 1.4241393
Ġan 3.1929154
Ġability 0.5587939
Ġto 0.0069575813
Ġimpede 4.2099586
Ġthe 1.567043
Ġspread 1.1072232
Ġof 0.14777201
Ġvarious 3.8890376
Ġcancer 1.9333243
Ġtypes 1.1587763
. 1.2080828
ĠThis 3.4472516
Ġbreakthrough 4.8072634
Ġhas 1.7557567
Ġraised 4.8463593
Ġhopes 1.526336
Ġof 1.842176
Ġimproved 4.80295
Ġpatient 2.4317758
Ġoutcomes 0.7432632
Ġand 0.8344174
Ġa 2.510535
Ġhigher 4.86515
Ġquality 0.5556082
Ġof 0.006335061
Ġlife 0.013994862
Ġfor 1.4800454
Ġthose 1.4644651
Ġaffected 2.6771548
Ġby 0.1135655
Ġcancer 0.6623419
. 0.10999618
Ċ 0.30905423
Despite 3.380298
Ġthese 1.4094498
Ġpromising 1.3412076
Ġresults 0.5325782
, 0.03319584
ĠBritish 2.3572981
ĠBi 0.006308308
otech 0.00013872207
ĠPl 1.8407232
c 3.8338017e-05
Ġfaces 2.2644598
Ġsignificant 1.8728707
Ġchallenges 1.0894017
Ġin 1.0384665
Ġtransforming 6.2638745
ĠMar 0.41326568
im 0.0007228014
ast 0.0022406206
at 0.0011704974
Ġfrom 2.0999105
Ġa 0.60498714
Ġpromising 0.4378421
Ġdrug 0.9878916
Ġcandidate 1.8825719
Ġinto 0.48425514
Ġa 0.094248645
Ġworld 5.664864
- 0.044206858
leading 3.769343
Ġblockbuster 2.6836486
. 0.55893505
ĠOne 5.030948
Ġof 0.6685443
Ġthe 0.06555237
Ġprimary 2.418134
Ġobstacles 1.1618853
Ġlies 2.926488
Ġin 0.12124892
Ġobtaining 4.5582304
Ġregulatory 1.1327499
Ġapproval 0.07512459
. 0.9578465
ĠThe 1.9626355
Ġdrug 1.890772
's 1.9567424
Ġsafety 3.5681503
Ġprofile 1.1044874
Ġand 2.2234068
Ġefficacy 1.5909876
Ġdata 4.9921665
Ġmust 0.8381873
Ġwithstand 5.8726854
Ġrigorous 1.3579955
Ġscrutiny 0.9664697
Ġfrom 1.0709833
Ġregulatory 1.4935211
Ġbodies 1.1905448
Ġsuch 2.1710992
Ġas 0.0014572776
Ġthe 0.008832141
ĠMedic 7.0308166
ines 0.0003133412
Ġand 0.08217606
ĠHealthcare 0.007816424
Ġproducts 0.6812712
ĠRegulatory 0.005690805
ĠAgency 0.020958824
Ġ( 0.30659556
MH 0.0114967795
RA 0.00029807872
). 1.3711644
ĠWhile 3.9951274
Ġpre 4.1911745
clinical 0.11237638
Ġtrials 1.65404
Ġindicate 3.4639077
Ġpositive 4.3785167
Ġresults 0.6628391
, 0.21357112
Ġfurther 4.8918605
Ġclinical 1.9300344
Ġstudies 2.5780005
Ġinvolving 5.0304728
Ġa 2.177774
Ġlarger 0.627091
Ġpool 2.9862933
Ġof 0.0055827284
Ġpatients 0.39732683
Ġare 1.3280319
Ġnecessary 1.0553387
. 2.6087391
ĠThese 3.5353231
Ġtrials 1.6110219
Ġcan 3.6006954
Ġbe 0.6497969
Ġcostly 1.4128429
Ġand 0.38847873
Ġtime 0.331169
- 0.14089526
consuming 0.067860514
, 0.34230626
Ġwhich 3.3017871
Ġmay 1.3672743
Ġhinder 2.609503
Ġthe 0.84165144
Ġdrug 1.1131417
's 0.027535005
Ġprogress 1.7153323
Ġtowards 2.1072505
Ġregulatory 1.1714535
Ġapproval 0.017509963
. 0.12031036
Ċ 0.3596217
Furthermore 2.8763335
, 0.00058925856
Ġcompetition 4.4898643
Ġwithin 3.1543682
Ġthe 0.030747663
Ġpharmaceutical 0.9928203
Ġindustry 0.38116997
Ġposes 3.4475038
Ġa 0.5019097
Ġformidable 3.5624182
Ġhurdle 3.8005147
. 1.1758159
ĠSeveral 3.8313663
Ġestablished 3.002383
Ġplayers 2.1190634
, 1.2099379
Ġarmed 9.106297
Ġwith 0.00084836746
Ġtheir 3.3162165
Ġown 0.106131844
Ġcutting 4.6878705
- 0.04692596
edge 0.00043450415
Ġcancer 1.6796434
Ġtreatments 1.4226073
, 0.062420394
Ġare 1.0923734
Ġvying 2.4049475
Ġfor 0.29300913
Ġdominance 3.0111136
Ġin 0.3912446
Ġthe 0.26826313
Ġmarket 1.0292691
. 0.10920256
ĠBritish 3.6680243
ĠBi 0.004166361
otech 0.0010104622
ĠPl 0.3019392
c 0.00036742157
Ġmust 1.0987686
Ġnavigate 4.493488
Ġthrough 2.4279392
Ġthis 0.7082903
Ġcompetitive 1.0950283
Ġlandscape 0.2706939
, 2.1563287
Ġdistinguishing 4.878402
ĠMar 0.77958244
im 0.00035001428
ast 0.00076783594
at 0.00026552632
's 2.7316146
Ġunique 2.1645632
Ġselling 2.7335162
Ġproposition 2.8042223
Ġand 1.465015
Ġestablishing 3.4084466
Ġits 2.0383754
Ġsuperiority 2.9579659
Ġover 0.3244311
Ġexisting 1.6907916
Ġalternatives 3.9283664
. 0.05983306
ĠThis 3.606551
Ġrequires 3.7977374
Ġsubstantial 2.7642527
Ġinvestments 2.839259
Ġin 0.3502705
Ġmarketing 1.0624965
, 1.6550128
Ġclinical 4.527114
Ġtrials 0.8338646
, 0.3492755
Ġand 0.11693723
Ġinfrastructure 6.7477784
Ġto 2.0811708
Ġeffectively 4.5311933
Ġpromote 2.733354
Ġand 1.839888
Ġdistribute 0.5548123
Ġthe 0.16225879
Ġdrug 0.133515
. 0.2509431
Ċ 0.3370776
Additionally 3.3046486
, 0.0007765466
Ġfinancial 7.1586432
Ġconsiderations 2.983942
Ġrepresent 3.8531516
Ġanother 2.1077845
Ġchallenge 2.3343184
Ġfor 1.2334517
ĠBritish 0.34624708
ĠBi 0.0024909566
otech 0.00013872207
ĠPl 0.08387146
c 7.5892516e-05
. 0.082203306
ĠThe 1.0760345
Ġcosts 4.15756
Ġassociated 0.89638346
Ġwith 0.0010721596
Ġclinical 2.1488178
Ġtrials 0.29070202
, 0.9624158
Ġmanufacturing 3.0148425
, 0.1503485
Ġmarketing 1.6458484
, 0.106672026
Ġand 0.21985883
Ġobtaining 6.3898034
Ġregulatory 0.026398445
Ġapprovals 3.216085
Ġdemand 7.239128
Ġsubstantial 1.7149124
Ġfunding 1.7550297
. 0.35114285
ĠInvestments 6.911172
Ġmust 2.954581
Ġbe 0.2849105
Ġsecured 3.4618149
Ġto 1.4166185
Ġmeet 4.0030885
Ġthese 0.7125518
Ġdemands 2.057293
, 0.58379066
Ġeither 4.7084317
Ġthrough 0.49908334
Ġpartnerships 3.2703054
, 1.5921313
Ġlicensing 1.6709455
Ġagreements 1.1806332
, 0.03654456
Ġor 0.16119118
Ġother 2.489158
Ġfinancial 2.7476888
Ġarrangements 0.95202
. 0.09982702
ĠSec 4.856374
uring 0.000923177
Ġsufficient 1.9750019
Ġfunding 0.63553184
Ġis 2.3128216
Ġessential 2.13933
Ġto 0.6572953
Ġsustain 5.1827765
Ġthe 0.8060938
Ġdrug 2.490435
's 0.17874382
Ġdevelopment 0.5345968
Ġand 0.72962856
Ġreach 5.4758058
Ġthe 1.3729829
Ġmarket 1.1939296
Ġeffectively 6.7049747
. 0.13847244
Ċ 0.13217895
Despite 2.8792214
Ġthese 0.42464024
Ġhurdles 3.2201118
, 0.019572869
ĠBritish 0.83928305
ĠBi 0.0029295273
otech 0.00011273176
ĠPl 0.038129866
c 0.00012465262
Ġremains 2.0082755
Ġoptimistic 0.80026627
Ġabout 0.59026945
ĠMar 0.7101821
im 0.00041745167
ast 0.0007079482
at 0.00023368915
's 0.063246205
Ġfuture 1.1661175
Ġpotential 3.3205562
. 0.1597339
ĠThe 0.7446307
Ġcompany 0.9232679
's 2.0881119
Ġcommitment 4.147861
Ġto 0.13026711
Ġresearch 2.894779
Ġand 0.102763586
Ġdevelopment 0.106461234
, 1.3373957
Ġcoupled 1.9556934
Ġwith 0.0009962613
Ġearly 6.284495
Ġpositive 3.0933254
Ġindications 3.6324348
, 0.90426004
Ġfost 6.774152
ers 0.002056941
Ġhope 1.6616981
Ġfor 1.1902014
Ġa 0.88503003
Ġsuccessful 1.5573837
Ġoutcome 2.5415132
. 0.08944393
ĠHowever 3.4260523
, 0.002066318
Ġa 3.583344
Ġconsiderable 2.5514712
Ġamount 0.29720873
Ġof 0.003929724
Ġtime 1.1035988
, 1.5862464
Ġdedication 4.6037507
, 0.0383538
Ġand 0.03328845
Ġresources 2.2358532
Ġwill 0.95528954
Ġdetermine 8.944355
ĠMar 2.3894458
im 0.0007067561
ast 0.0007730849
at 0.00030082333
's 0.0011650071
Ġjourney 6.1067996
Ġfrom 1.1055224
Ġan 3.7079515
Ġexciting 1.7571106
Ġprospect 3.0098836
Ġto 0.13072567
Ġa 0.15576792
Ġbreakthrough 4.3176546
Ġblockbuster 2.7085822
Ġdrug 3.2536743
. 0.028739033
Ċ 0.3386639
In 3.440378
Ġconclusion 4.862911
, 0.07753118
ĠBritish 1.0358818
ĠBi 0.013836751
otech 0.00088398176
ĠPl 0.13781992
c 0.00020811372
's 1.0792501
Ġcancer 2.2605088
Ġdrug 0.21973148
ĠMar 1.361092
im 0.00051960035
ast 0.0005800119
at 0.0011862527
Ġhas 1.5161413
Ġshown 1.180908
Ġtremendous 2.3465497
Ġpromise 1.1718767
Ġin 0.41358125
Ġearly 1.5543894
Ġtrials 2.4805152
. 0.62346655
ĠHowever 0.94117326
, 0.002885529
Ġregulatory 4.1898565
Ġapproval 0.7802143
, 0.6442042
Ġthe 4.683339
Ġcompetitive 0.36783844
Ġlandscape 0.17693754
, 0.0414766
Ġand 0.2298305
Ġthe 3.817266
Ġneed 2.0410712
Ġfor 0.09418341
Ġsubstantial 1.3315485
Ġfunding 0.53939587
Ġare 3.5302656
Ġsignificant 2.0017235
Ġobstacles 1.1491289
Ġthat 1.2864918
Ġmust 0.70106566
Ġbe 0.0074126422
Ġovercome 0.1753357
Ġto 1.2020452
Ġbring 2.3794794
ĠMar 2.0148866
im 0.0010760982
ast 0.0015923061
at 0.00010080995
Ġto 0.06581455
Ġmarket 0.5597054
Ġsuccessfully 3.0763853
. 0.029077519
ĠThe 2.8580847
Ġjourney 4.5610533
Ġto 1.6262064
Ġbecoming 3.8017912
Ġa 0.052262247
Ġblockbuster 0.4518453
Ġdrug 0.61296487
Ġmay 3.5499036
Ġbe 0.6447575
Ġchallenging 3.812718
, 0.21495117
Ġbut 0.05637733
Ġthe 1.2476438
Ġpotential 1.3181733
Ġbenefits 1.8335291
Ġfor 1.6301383
Ġcancer 1.2104251
Ġpatients 0.112973265
Ġmake 1.8579396
Ġit 0.9710123
Ġa 2.3254218
Ġjourney 2.693719
Ġworth 0.42170516
Ġpursuing 1.8899453
. 0.023231795
